Trial · NCT04434092
Results by group83
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 83
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Transfusion Avoidance (TA) | Arm A: Crovalimab | 65.7 | 95% Confidence Interval 56.91 to 73.52 | percentage of participants | |
| Percentage of Participants With Transfusion Avoidance (TA) | Arm B: Eculizumab | 68.1 | 95% Confidence Interval 55.67 to 78.53 | percentage of participants | |
| Percentage of Participants With Hemolysis Control Measured by LDH | Arm A: Crovalimab | 79.3 | 95% Confidence Interval 72.86 to 84.48 | percentage of participants | |
| Percentage of Participants With Hemolysis Control Measured by LDH | Arm B: Eculizumab | 79.0 | 95% Confidence Interval 69.66 to 85.99 | percentage of participants | |
| Percentage of Participants With Breakthrough Hemolysis (BTH) | Arm A: Crovalimab | 10.4 | 95% Confidence Interval 6.04 to 17.21 | percentage of participants | |
| Percentage of Participants With Breakthrough Hemolysis (BTH) | Arm B: Eculizumab | 14.5 | 95% Confidence Interval 7.54 to 25.50 | percentage of participants | |
| Percentage of Participants With Stabilization of Hemoglobin | Arm A: Crovalimab | 63.4 | 95% Confidence Interval 54.63 to 71.45 | percentage of participants | |
| Percentage of Participants With Stabilization of Hemoglobin | Arm B: Eculizumab | 60.9 | 95% Confidence Interval 48.35 to 72.17 | percentage of participants | |
| Change From Baseline in Fatigue Assessed by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale | Arm A: Crovalimab | Baseline | 36.02 | Standard Error 0.877 | score on scale |
| Change From Baseline in Fatigue Assessed by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale | Arm B: Eculizumab | Baseline | 35.09 | Standard Error 1.408 | score on scale |
| Change From Baseline in Fatigue Assessed by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale | Arm A: Crovalimab | Change at Week 25 | 7.79 | Standard Error 0.661 | score on scale |
| Change From Baseline in Fatigue Assessed by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale | Arm B: Eculizumab | Change at Week 25 | 5.15 | Standard Error 0.880 | score on scale |
| Change From Baseline in Absolute Reticulocyte Count | Arm A: Crovalimab | Baseline | 2865.56 | Standard Deviation 22637.24 | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm B: Eculizumab | Baseline | 164.26 | Standard Deviation 114.27 | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm A: Crovalimab | Change at Week 1 Day 1 | -58.50 | Standard Deviation NA | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm A: Crovalimab | Change at Week 2 | 542.90 | Standard Deviation 4314.07 | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm B: Eculizumab | Change at Week 2 | 105.88 | Standard Deviation 601.77 | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm A: Crovalimab | Change at Week 3 | -71.08 | Standard Deviation 533.01 | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm B: Eculizumab | Change at Week 3 | -15.62 | Standard Deviation 53.79 | 10^9 cells/liter (L) |
| Change From Baseline in Absolute Reticulocyte Count | Arm A: Crovalimab | Change at Week 4 | 8.52 | Standard Deviation 58.01 | 10^9 cells/liter (L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04434092/results